Molecular Biology Reports

, Volume 46, Issue 1, pp 647–656 | Cite as

Methyl jasmonate a stress phytohormone attenuates LPS induced in vivo and in vitro arthritis

  • S. M. GunjegaonkarEmail author
  • T. S. Shanmugarajan
Original Article


The objective of present study was to screen the effect of methyl jasmonate (MJ) in lipopolysaccharide (LPS) induced in vivo and in vitro arthritis. Arthritis was induced in wistar rats by intraplantar administration of LPS (1 mg/Kg) and effect of MJ was screened in two doses (20, 40 mg/Kg, IP), indomethacin (30 mg/Kg p.o) was used as standard. The anti-nociceptive effect was evaluated through behavioral assessment viz. cold allodynia, Paw thermal hyperalgesia and Tail cold hyperalgesia on 1st, 7th, 14th, 21st and 28th day. The Myeloperoxidase (MPO), Cathepsin D (CAT-D), articular elastase (ELA), and nitrite levels were estimated in articular cartilage tissues on the 28th day. Rat paw was subjected to histopathology after radiological examination on 28th day. In vitro effect of MJ was evaluated for three concentrations (5, 10, 20 µg/ml) in LPS (1 µg/ml) stimulated CHNO001 cells. Estimation of pro-inflammatory mediators was carried using ELISA. Significant reduction in pro-inflammatory mediators was observed in MJ treated chondrocyte cells. % proteinase inhibition was assessed for 10, 50, 100, 250, 500 µg/mL and IC50 was found 266.15. MJ significantly reducesnociceptive response against hot and cold allodynia. Significant reduction in MPO, ELA, and nitrite levels was observed. The CAT-D levels significantly restored. Minimum focal mild infiltration of lymphocytes was observed at synovial area in standard and MJ treated rats. These current studies conclude that MJ has protective role in arthritis.


Methyl jasmonate Lipopolysaccharides Anti-inflammatory Antinociceptive Chondrocyte 



We are thankful to Dean, School of Pharmaceutical Sciences, Vels Institute of Science, Technology and Advanced Studies, for providing necessary facilities to carry out the research. The research was not funded (Financial and material support) by any government, the non-government agency the expenses are barred by authors only.

Compliance with ethical standards

Conflict of interest

Authors declare that there is no conflict of interest relevant to this study.


  1. 1.
    Heinegard D (2009) Proteoglycans and more from molecules to biology. Int J Exp Pathol 90(6):575–586CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Adams MA, Dolan P, McNally DS (2009) The internal mechanical functioning of intervertebral discs and articular cartilage, and its relevance to matrix biology. Matrix Bio 28(7):384–389CrossRefGoogle Scholar
  3. 3.
    Mollon B, Kandel R, Chahal J, Theodoropoulos J (2013) Clinical status of cartilage tissue regeneration in humans. Osteoarthr Cartil 21(12):1824–1833CrossRefPubMedGoogle Scholar
  4. 4.
    Rujirek C, Siriwan O, Siriwan T, Prachya K, Ampai P, Vichai R (2012) Chondroprotective potential of bioactive compounds of Zingiber cassumunar Roxb. against cytokine-induced cartilage degradation in explant culture. J Med Plant Res 6(39):5204–5213CrossRefGoogle Scholar
  5. 5.
    Henrotin YE, Bruckner P, Pujol JPL (2003) The role of reactive oxygen species in homeostasis and degradation of cartilage. Osteoarthr Cartil 11(10):747–755CrossRefPubMedGoogle Scholar
  6. 6.
    Hiran TS, Moulton PJ, Hancock JT (1999) Detection of superoxide and NADPH oxidase in porcine articular chondrocytes. Free Radic Biol Med 23(5):736–743CrossRefGoogle Scholar
  7. 7.
    Hassan Heidar EL, Fareed FA, Waleed NH, Refaat AE, Mohamed AH (2014) The impact of antioxidants on inflammation and oxidative stress markers in osteoarthritis rat model: scanning electron microscope insights. Am J Pharmacol Toxicol 9(2):157–167CrossRefGoogle Scholar
  8. 8.
    Creelman RA, Mullet JE (1995) Jasmonic acid distribution and action in plants: regulation during development and response to biotic and abiotic stress. Proc Natl Acad Sci USA 92(10):4114–4119CrossRefPubMedGoogle Scholar
  9. 9.
    Abimbola SO, Solomon U (2011) Anti-nociceptive effects of methyl jasmonate in experimental animals. J Nat Med 65(3):466–470Google Scholar
  10. 10.
    Oritoke MA, Solomon U, Olajide S, Annafi F, Adewole A, Osarume O (2015) Effects of methyl jasmonate on acute stress responses in mice subjected to forced swim and anoxic tests. Sci Pharm 83(4):635–644CrossRefGoogle Scholar
  11. 11.
    Sadiq U, Mishrab NK, Kaushal P, Mir S, Nehaa MA, Sayeed A (2012) Protective effect of rutin in attenuation of collagen-induced arthritis in wistar rat by inhibiting inflammation and oxidative stress. Ind J Rheumatol 7(4):191–198CrossRefGoogle Scholar
  12. 12.
    Pabreja K, Dua K, Sharma S, Padi SS, Kulkarni SK (2011) Minocycline attenuates the development of diabetic neuropathic pain: possible anti-inflammatory and anti-oxidant mechanisms. Eur J Pharmacol 661(1–3):15–21CrossRefPubMedGoogle Scholar
  13. 13.
    Harquin SF, David ET, Zogo E, Bodo JC, Azanfack NC, Lissia TH, Eyong KO (2015) Anti-inflammatory and anti-arthritic activity of a methanol extract from Vitellaria paradoxa stem bark. Pharmacogn Res 7(4):367–377CrossRefGoogle Scholar
  14. 14.
    Bhardwaj HC, Muthuraman A, Hari KSL, Navis S (2016) Antioxidative and anti-inflammatory potentials of ambroxol in ameliorating vincristine induced peripheral neuropathic pain in rats. J Neuroinfect Dis 7(1):1–7Google Scholar
  15. 15.
    Mamatha K, Rodda HC, Ciddi V, Bookya K (2013) Anti-arthritic activity of root bark of Oroxylumindicum (L.) vent against adjuvant-induced arthritis. Pharmacogn Res 5(2):121–128CrossRefGoogle Scholar
  16. 16.
    Umar S, Kumar A, Sajad M, Zargan J, Ansari M, Ahmad S (2013) Hesperidin inhibits collagen-induced arthritis possibly through suppression of free radical load and reduction in neutrophil activation and infiltration. Rheumatol Int 33(3):657–663CrossRefPubMedGoogle Scholar
  17. 17.
    Anthony U, Veronila K, Taryn Y, Alfred M (2015) Prevalence of arthritis in Africa: a SYSTEMATIC review and Meta-analysis. PLoS ONE 10(8):e0133858CrossRefGoogle Scholar
  18. 18.
    Lukas G, Brindle SD, Greengard P (1971) The route of absorption of intraperitoneally administered compounds. J Pharmacol Exp Ther 178:562–566PubMedGoogle Scholar
  19. 19.
    Turner PV, Brabb T, Cynthia P (2011) Administration of substances to laboratory animals: routes of administration and factors to consider. J Am Assoc Lab Anim 50(5):600–613Google Scholar
  20. 20.
    Dos SG, Kutuzov MA, Ridge KM (2012) The inflammasome in lung diseases. Am J Physiol Lung Cell Mol Physiol 303(8):627–633CrossRefGoogle Scholar
  21. 21.
    Christopher BL, Margaret MS (2008) Animal models of osteoarthritis. Curr Rheumatol Rev 4(3):175–182CrossRefGoogle Scholar
  22. 22.
    Troyer H (1982) Experimental models of osteoarthritis: a review. Semin Arthritis Rheum 11(3):362–374CrossRefPubMedGoogle Scholar
  23. 23.
    Collins KH, Reimer RA, Seerattan RA, Leonard TR, Herzog W (2015) Using diet-induced obesity to understand a metabolic subtype of osteoarthritis in rats. Osteoarthr Cartil 23(6):957–965CrossRefPubMedGoogle Scholar
  24. 24.
    Stoop R, Peter MV, Buma P, Hollander AP, Billinghurst RC, Poole AR (1999) Type II collagen degradation in spontaneous osteoarthritis in C57Bl/6 and BALB/c mice. Arthritis Rheum 42(11):2381–2389CrossRefPubMedGoogle Scholar
  25. 25.
    Hai W, Zhi-Ran C (2014) Anti-inflammatory effects of (−) epicatechin in lipopolysaccharide stimulated raw 264.7 macrophages. Trop J Pharm Res 13(9):1415–1419CrossRefGoogle Scholar
  26. 26.
    Tomoyuki M, Gregory MC, Burhan G, Laura BM, Guangheng L, Arvydas U (2009) Cartilage repair in a rat model of osteoarthritis through intra-articular transplantation of muscle-derived stem cells expressing bone morphogenetic protein 4 and soluble flt-1. Arthri Rheum 60(5):1390–1405CrossRefGoogle Scholar
  27. 27.
    Byeong SC (2018) Pretreatment of low-dose and super-low-dose LPS on the production of in vitro LPS-induced inflammatory mediators. Toxicol Res 34(1):65–73CrossRefGoogle Scholar
  28. 28.
    Dong L, Li H, Wang S, Li Y (2009) Different doses of lipopolysaccharides regulate the lung inflammation of asthmatic mice via TLR4 pathway in alveolar macrophages. J Asthma 46(3):229–233CrossRefPubMedGoogle Scholar
  29. 29.
    Yeamin H, Richard FK, David E (2013) Impact of lipopolysaccharide-induced inflammation on the disposition of the aminocephalosporin C. Antimicrob Agents Chemother 57(12):6171–6178CrossRefGoogle Scholar
  30. 30.
    Sehic E, Li S, Ungar AL, Blatteis CM (1998) Complement reduction impairs the febrile response of guinea pigs to endotoxin. Regul Integr Physiol 274(6):1594–1603CrossRefGoogle Scholar
  31. 31.
    Bradley JR (2008) TNF-mediated inflammatory disease. J Pathol 214(2):149–160CrossRefPubMedGoogle Scholar
  32. 32.
    Marcela PC, Gustavo CC (2016) Human interleukin 2 (IL-2) promotion of immune regulation and clinical outcomes: a review. J Cytokine Biol 1(2):1–4Google Scholar
  33. 33.
    Sinnathambi A, Papiya MM, Lohidasan S, Purnima A (2011) Anti-arthritic and antioxidant activity of leaves of Alstoniascholaris Linn.R.Br. Eur J Integr Med 3(2):83–90CrossRefGoogle Scholar
  34. 34.
    Artmann G, Fehr K, Boni A (1977) Cathepsin D agglutinators in rheumatoid arthritis I increased CDA titers in serum and synovial fluid of patients with sero positive RA. Arthritis Rheumatol 20(5):1105–1113CrossRefGoogle Scholar
  35. 35.
    Louisa BA, Emmanuelle M, Duha F, Ashok K, Eli R, Yael B (2015) Detecting cathepsin activity in human osteoarthritis via activity-based probes. Arthritis Res Ther 17(69):1–13Google Scholar
  36. 36.
    Momohara S, Kashiwazaki S, Inoue K, Saito S, Nakagawa T (1997) Elastase from polymorphonuclear leukocyte in articular cartilage and synovial fluids of patients with rheumatoid arthritis. Clin Rheumatatol 16(2):133–140CrossRefGoogle Scholar
  37. 37.
    Vuolteenaho K, Moilanen T, Knowles RG, Moilanen E (2007) The role of nitric oxide in osteoarthritis. Scandi J Rheumatol 36(4):247–258CrossRefGoogle Scholar
  38. 38.
    Yvonne R, Caroline O, Steffen G (2007) Proteinases in the joint: clinical relevance of proteinases in joint destruction. Arthr Res Ther 9(211):1–10Google Scholar
  39. 39.
    Kaneko M, Tomita T, Nakase T, Ohsawa Y, Seki H, Takeuchi E (2001) Expression of proteinases and inflammatory cytokines in subchondral bone regions in the destructive joint of rheumatoid arthritis. Rheumatology 40(3):247–255CrossRefPubMedGoogle Scholar
  40. 40.
    Fionula MB, Iain BM (2008) Evidence that cytokines play a role in rheumatoid arthritis. J Clin Investi 118(11):3537–3545CrossRefGoogle Scholar
  41. 41.
    Ricciotti E, FitzGerald GA (2011) Prostaglandins and inflammation. Arterioscler, Thromb Vasc Biol 31(5):986–1000CrossRefGoogle Scholar
  42. 42.
    Murphy G, Lee MH (2005) What are the roles of metalloproteinases in cartilage and bone damage? Ann Rheum Dis 64(4):44–47Google Scholar
  43. 43.
    Gunjegaonkar SM, Shanmugarajan TS (2018) Potential of plant stress hormone methyl jasmonate against lipopolysaccharide attenuated oxidative stress and arthritis in experimental animals. Int J Green Pharm 12(3):561–569Google Scholar

Copyright information

© Springer Nature B.V. 2018

Authors and Affiliations

  1. 1.Department of Pharmacology, School of Pharmaceutical SciencesVels Institute of Science, Technology and Advanced StudiesChennaiIndia

Personalised recommendations